Human neonatal stem cell‐derived skin substitute improves healing of severe burn wounds in a rat model

Conventional approaches can repair minor skin injuries; however, severe burn injuries require innovative approaches for efficient and better wound repair. Recent studies indicate that stem cell‐based regenerative therapies can restore severe damaged skin both structurally and functionally. The current study aims to evaluate the wound healing potential of skin substitute derived from human neonatal stem cells (hNSCs) using a severe burn injury rat model. Amniotic epithelial cells (AECs) and mesenchymal stem cells (MSCs) were isolated from placenta (a source of neonatal stem cells) by explant culture method. After characterization, AECs and umbilical cord‐MSCs were differentiated into keratinocyte and fibroblasts, respectively. Morphological changes, and expression of corresponding keratinocyte and fibroblast specific markers were used to verify differentiation into respective lineage. A skin substitute was developed by mixing hNSCs‐derived skin cells (hNSCs‐SCs) in plasma for transplantation in a rat model of severe burn injury. Results indicated that placenta‐derived AECs and MSCs were efficiently differentiated into skin cells, that is, keratinocytes and fibroblasts, respectively, as indicated by morphological changes, immunostaining, and polymerase chain reaction analysis. Further, transplantation of hNSCs‐SCs seeded in plasma significantly improved basic skin architecture, re‐epithelization rate, and wound healing concurrent with reduced apoptosis. In conclusion, neonatal stem cell‐derived skin substitute efficiently improved severe burn wounds in a rat model of burn injury. Unique properties of placenta‐derived stem cells make them superlative candidates for the development of “off‐the‐shelf” artificial skin substitutes for future use.